This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Safety of Dabigatran Etexilate in Blood Clot Preve...
Clinical trial

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Read time: 1 mins
Last updated:21st Jul 2014

This open-label, single arm prospective cohort study will assess the safety of dabigatran etexilate in secondary prevention of venous thromboembolism in paediatric patients. Children from 0 to less than 18 years of age will be eligible to participate.

Category Value
Study start date 2014-07-21

View full details